Cloning and Expression of Human Insulin-Like Growth Factor Binding Protein 3

References

• Aviv H., Leder P. Purification of biologically active globin messenger RNA by chromatography on oligo-thymidylic acid-cellulose. Proc. Natl. Acad. Sa. USA 1972; 69: 1408–1412
   PubMed Web of Science ®Google Scholar
• Baxter R. C. The somatomedins: insulin-like growth factors. Adv. Clin. Chem 1986; 25: 49–115
   PubMed Web of Science ®Google Scholar
• Baxter R. C. Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex. J. Clin. Endocrinol. Metab 1988; 67: 265–272
   PubMed Web of Science ®Google Scholar
• Baxter R. C., Cowell C. T. Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma. J. Clin. Endocrinol. Metab 1987; 65: 432–440
   PubMed Web of Science ®Google Scholar
• Baxter R. C., Martin J. L. Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. J. Clin. Invest 1986; 78: 1504–1512
   PubMed Web of Science ®Google Scholar
• Baxter R. C, Martin J. L., Tyler M. I., Howden M. E. Growth hormone-dependent insulin-like growth factor (IGF) binding protein from human plasma differs from other human IGF binding proteins. Biochem. Biophys. Res. Commun 1986; 139: 1256–1261
   Google Scholar
• Baxter R. C, Martin J. L., Wood M. H. Two immuno-reactive binding proteins for insulin-like growth factors in human amniotic fluid: relationships to fetal maturity. J. Clin. Endocrinol. Metab 1987; 65: 423–431
   PubMed Web of Science ®Google Scholar
• Bennington J., Spencer E. M., Reber K. Immunoper-oxidase localization of insulin-like growth factor-1 containing tissue. Insulin-like Growth Factors/Somatomedins, E. M. Spencer. Walter de Gruyter, New York 1983; 563–570
   Google Scholar
• Brawerman G. Determinants of messenger RNA stability. Cell 1987; 48: 5–6
   PubMed Web of Science ®Google Scholar
• Brewer M. T, Stetler G. L., Squires C. H., Thompson R. C., Busby W. H., Clemmons D. R. Cloning, characterization, and expression of a human insulin-like growth factor binding protein. Biochem. Biophys. Res. Commun 1988; 152: 1289–1297
   PubMed Web of Science ®Google Scholar
• Brinkman A., Groffen C, Kortleve D. J., Geurts van Kessel A., Drop S. L. Isolation and characterization of a cDNA encoding the low molecular weight insulin-like growth factor binding protein (1BP-1). EMBO J 1988; 7: 2417–2423
   PubMed Web of Science ®Google Scholar
• Brown A. L., Chiariotti L., Orlowski C. C, Mehlman T., Burgess W. H., Ackerman E. J., Bruni C. B., Rechler M. W. Nucleotide sequence and expression of a cDNA clone encoding a fetal rat binding protein for insulin-like growth factors. J. Biol. Chem 1989; 264: 5418–5154
   Web of Science ®Google Scholar
• Cascieri M. A., Saperstein R., Hayes N. S., Green B. G., Chicchi G. G., Applebaum J., Bayne M. L. Serum half-life and biological activity of mutants of human insulinlike growth factor 1 which do not bind to serum binding proteins. Endocrinology 1987; 123: 373–387
   Web of Science ®Google Scholar
• Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294–5299
   PubMed Web of Science ®Google Scholar
• Daughaday W. H., Hall K., Raben M. S., Salmon W. D., Jr., Brande J. L., van den A., van Wyk J. J. Somatomedin: proposed designation for sulphation factor. Nature 1972; 235: 107
   PubMed Web of Science ®Google Scholar
• Daughaday W. H., Ward A. P., Goldberg A. C., Trivedi B., Kapadia M. Characterization of somatomedin binding in human serum by ultracentrifugation and gel filtration. J. Clin. Endocrinol. Metab 1982; 55: 916–921
   PubMed Web of Science ®Google Scholar
• Drop S. L., Valiquette G., Guyda H. J., Corvol M. T., Posner B. I. Partial purification and characterization of a binding protein for insulin-like activity (ILAs) in human amniotic fluid: a possible inhibitor of insulin-like activity. Acta Endocrinol 1979; 90: 505–518
   PubMedGoogle Scholar
• Drop S. L. S., Kortieve D. J., Guyda H. J. Isolation of a somatomedin-binding protein from preterm amniotic fluid. Development of a radioimmunoassay. J Clin. Endocrinol. Metab 1984; 59: 899–907
   PubMed Web of Science ®Google Scholar
• Drop S. L. S., Kortleve D. J., Guyda H. J., Posner B. I. Immunoassay of a somatomedin-binding protein from human amniotic fluid: levels in fetal, neonatal, and adult sera. J. Clin. Endocrinol. Metab 1984; 59: 908–915
   PubMed Web of Science ®Google Scholar
• Elgin R. G., Busby W. H., Clemmons D. R. An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc. Natl. Acad. Sa. USA 1987; 84: 3254–3258
   PubMed Web of Science ®Google Scholar
• Furlanetto R. W. The somatomedin C binding protein: evidence for a heterologous subunit structure. J. Clin. Endocrinol. Metab 1980; 51: 12–9
   PubMed Web of Science ®Google Scholar
• Graham F. L., van der Eb AJ. A new technique for the assay of infectivitv of human adenovirus 5 DNA. Virology 1973; 52: 456–467
   PubMed Web of Science ®Google Scholar
• Gubler U., Hoffman B. J. A simple and very efficient method for generating cDNA libraries. Gene 1983; 25: 263–269
   PubMed Web of Science ®Google Scholar
• Gunning P., Leavitt J., Muscat G., Ng SY., Kedes L. A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proc. Natl. Acad. Sci. USA 1987; 84: 4831–4835
   PubMed Web of Science ®Google Scholar
• Hintz R. L. Plasma forms of somatomedin and the binding protein phenomenon. Clin. Endocrinol. Metab 1984; 13: 31–42
   PubMedGoogle Scholar
• Hintz R. L., Liu F. Demonstration of specific plasma protein binding sites for somatomedin. J. Clin. Endocrinol. Metab 1977; 45: 988–995
   PubMed Web of Science ®Google Scholar
• Hintz R. L., Liu F., Rosenfeld R. G., Kemp S. F. Plasma somatomedin-binding proteins in hypopituitarism: changes during growth hormone therapy. J. Clin. Endocrinol. Metab 1981; 53: 100–104
   PubMed Web of Science ®Google Scholar
• Hossenlopp P., Seurin D., Segovia-Quinson B., Hardouin S., Binoux M. Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal. Biochem 1986; 154: 138–143
   PubMed Web of Science ®Google Scholar
• Knauer D. J., Smith G. L. Inhibition of biological activity of multiplication-stimulating activity by binding to its carrier protein. Proc. Natl. Acad. Sci. USA 1980; 77: 7252–7256
   PubMed Web of Science ®Google Scholar
• Koistinen R., Kalkkinen N., Huhtala M-L., Seppala M., Bohn H., Rutanen E-M. Placenta protein 12 is a decidual protein that binds somatomedin and has an identical N-terminal amino acid sequence with somatomedin-binding protein from human amniotic fluid. Endocrinology 1986; 118: 1375–1378
   PubMed Web of Science ®Google Scholar
• Kozak M. Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acid Res 1984; 12: 857–872
   PubMed Web of Science ®Google Scholar
• Lee P. D., Powell D. R., Li C. H., Bohn H., Liu F., Hintz R. L. High molecular weight forms of insulin-like growth factor 11 and its binding protein identified by protein immunoblotting. Biochem. Biophys. Res. Commun 1988; 152: 1131–1137
   Google Scholar
• Lee Y. L., Hintz R. L., James P. M., Lee P. D. K., Shively J. E., Powell D. R. Insulin-like growth factor (IGF) binding protein complementary deoxyribonucleic acid from human HEP G2 hepatoma cells: predicted protein sequence suggests an IGF binding domain different from those of the IGF-I and IGF-II receptors. Mol. Endocrinol 1988; 2: 404–411
   PubMed Web of Science ®Google Scholar
• Luthman H., Soderling-Barros J., Persson B., Engberg C, Stern I., Lake M., Franzen S., Israelsson M., Raden B., Lindgren B., Hjelmqvist L., Enerback S., Carlsson P., Bjurssel G., Povoa G., Hall K., Jornvall H. Human insulin-like growth-factor-binding protein. Low-molecular-mass form: protein sequence and cDNA cloning. Eur. J. Biochem 1989; 180: 259–265
   PubMedGoogle Scholar
• Maniatis T., Frisch E. F., Sambrook J. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 1982
   Google Scholar
• Martin J. L., Baxter R. C. Antibody against acid-stable insulin-like growth factor binding protein detects 150,000 mol wt growth hormone-dependent complex in human plasma. J. Clin. Endocrinol. Metab 1985; 61: 799–801
   PubMed Web of Science ®Google Scholar
• Martin J. L., Baxter R. C. Insulin-like growth factor-binding protein from human plasma. Purification and characterization. J. Biol. Chem 1986; 261: 8754–8760
   PubMed Web of Science ®Google Scholar
• Morgan D. O., Edman J. C, Standring D. N., Fried V. A., Smith M. C, Roth R. A., Rutter W. J. Insulin growth factor II receptor as a multifunctional binding protein. Nature 1987; 329: 301–307
   PubMed Web of Science ®Google Scholar
• Mottola C, MacDonald R. G., Brackett J. L., Mole J. E., Anderson J. K., Czech M. P. Purification and amino-terminal sequence of an insulin-like growth factor-binding protein secreted by rat liver BRL-3A cells. J. Biol. Chem 1986; 261: 11180–11188
   PubMed Web of Science ®Google Scholar
• Mullis K., Faloona F., Scharf S., Saiki R., Horn G., Erlich H. Specific enzymatic amplification of DNA in vitro: The polymerase chain reaction. Cold Spring Harbor Symp. Quant. Biol 1986; 51: 263–273
   PubMedGoogle Scholar
• Perkins S. N., Zangger I., Eberwine J. H., Barchas J. D., Jansen M., Hintz R., Hoffman A. R. Tissue distribution of insulin-like growth factor I and insulin-like growth factor II messenger RNA. Endocrine Soc. 68th. Annu. Mtg 1986; 253(94), Abstr
   Google Scholar
• Perlman D., Halvorson H. O. A putative signal peptidase recognition site and sequence in eukaryotic and pro-karyotic signal peptides. J. Mol. Biol 1983; 167: 391–409
   PubMed Web of Science ®Google Scholar
• Povoa G., Roovete A., Hall K. Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol 1984; 107: 563–570
   PubMedGoogle Scholar
• Povoa G., Isaksson M., Jornvall H., Hall K. The somatomedin-binding protein isolated from a human hepatoma cell line is identical to the human amniotic fluid somatomedin-binding protein. Biochem. Biophys. Res 1985; 128: 1071–1078
   PubMed Web of Science ®Google Scholar
• Romanus J. A., Terell J. E., Yang Y. W. H., Nissley S. P., Rechler M. M. Insulin-like growth factor carrier proteins in neonatal and adult rat serum are immunologically different: demonstration using a new radioimmunoassay for the carrier protein from BRL-3A rat liver cells. Endocrinology 1986; 118: 1743–1758
   PubMed Web of Science ®Google Scholar
• Russell D. W., Schneider W. J., Yamamoto T., Luskey K. L., Brown M. S., Goldstein J. L. Domain map of the LDL receptor: sequence homology with the epidermal growth factor precursor. Cell 1984; 37: 577–585
   PubMed Web of Science ®Google Scholar
• Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 1977; 74: 5463–5467
   PubMed Web of Science ®Google Scholar
• Smith G. L. Somatomedin carrier proteins. Mol. Cell. Endocrinol 1984; 34: 83–89
   PubMed Web of Science ®Google Scholar
• Spencer E. M. Anterior pituitory and somatomedins: 11. Somatomedins. Basic and Clinical Endocrinology, F. S. Greenspan, P. H. Forshan. Lange Medical Publications, California 1986; 95–106
   Google Scholar
• Spencer E. M. Role of somatomedin C/insulin-like growth factor I binding protein in regulation of growth. J. Anim. Sci. (Suppl. 2) 1986; 65: 180–185
   Google Scholar
• Spencer E. M., Steenfos H., Strathearn M., Lomri N., Spratt S. K., Hurt T. K. Molecular biology and physiology of the insulin-like growth factor binding protein 3, the acid-stable unit of the 150 K serum insulin-like growth factor binding complex. Insulin-Like Groit'th Factor Binding Proteins, S. L. S. Drop, R. L. Hintz. Elsevier Science, New York 1989
   Google Scholar
• Takahashi N., Takahashi Y., Putnam F. Structure of human hemopexin: O-glycosyl and N-glycosyl sites and unusual clustering of tryptophan residues. Proc. Natl. Acad. Sci. USA 1984; 88: 2021–2025
   Google Scholar
• Ullrich A., Coussens L., Hayflick J. S., Dull T. J., Gray A., Tarn A. W., Lee J., Yarden Y., Libermann T. A., Schles-singer J. et al Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 1984; 309: 418–425
   PubMed Web of Science ®Google Scholar
• White R. M., Nissley S. P., Moses A. C, Rechler M. M., Johnsonbaugh R. E. The growth hormone dependence of a somatomedin-binding protein in human serum. J. Clin. Endocrinol. Metab 1981; 53: 49–57
   PubMed Web of Science ®Google Scholar
• Wilkins J. R., D'Ercole A. J. Affinity-labeled plasma somatomedin-C/insulin-like growth factor I binding proteins. Evidence of growth hormone dependence and subunit structure. J. Clin. Invest 1985; 75: 1350–1358
   PubMed Web of Science ®Google Scholar
• Wilson T., Treisman R. Removal of poly (A) and consequent degradation of c-fos mRNA facilitated by 3' Abl-rich sequences. Nature 1988; 336: 396–399
   PubMed Web of Science ®Google Scholar
• Wood W. I., Cachianes G., Henzel W. J., Winslow F. A., Spencer S. A., Hellmiss R., Martin J. L., Baxter R. C. Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein. Mol. Endocrinol 1988; 2: 1176–1185
   PubMed Web of Science ®Google Scholar
• Yamamoto T., Davis C. G., Brown M. S., Schneider W. J., Casey M. L., Goldstein J. L., Russell D. W. The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA. Cell 1984; 39: 27–38
   PubMed Web of Science ®Google Scholar
• Zapf J., Schoenle E., Jagars G., Sand I., Grunwald J., Froesch E. R. Inhibition of the action of nonsuppres-sible insulin-like activity on isolated rat fat cells by binding to its carrier protein. J. Clin. Invest 1979; 63: 1077–1084
   PubMed Web of Science ®Google Scholar